Abstract
Before the dawn of molecular biology and recombinant DNA technology, vaccines were essentially natural products. Such vaccines comprise live attenuated disease agents, killed organisms, or biochemically isolated subcomponents or subfractions of the disease causing agent. The fact that these classical vaccines are natural products ensured that, if sufficient care were taken (during attenuation, inactivation, or subunit isolation), the important protective epitopes represented on the disease agent could be preserved on the vaccine candidate in proper immunogenic form.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beasley, R.P. and Hwang, L.-Y. (1984), Epidemiology of hepatocellular carcinoma, Viral Hepatitis and Liver Disease. (G.N. Vyas, J.H. Dienstag and J.H. Hoofnagle eds.), Grune & Stratton, Orlando, pp. 209–224.
Bhatnagar, P.K., Papas, E., Blum, H.E., Milich, D.R., Nitecki, D., Karels, M.J. and Vyas, G.H. (1982), Immune Response to Synthetic Peptide Analogues of Hepatitis B Surface Antigen Specific for the a Determinant. Proc. Natl. Acad. Sci. (U.S.A.) 79, 4400–4404.
Brown, S.E., Howard, C.R., Zuckerman, A.J. and Steward, M.W. (1984), Determination of the Affinity of Antibodies to Hepatitis B Surface Antigen in Human Sera. J. Immunol. Meth. 72, 41–48.
Carty, C.E., Montgomery, D.L., Hagopian, A. Burke, P., Dunn, N., Schultz, L.D., Kniskern, P.J., Maigetter, R.Z., and Ellis, R.W. (1989), Regulated Expression of Hepatitis B Surface Antigen Containing the PreS2 Domain in Recombinant Yeast. Submitted to J. Industrial Micro.
Ciriacy, M. (1975), Genetics of Alcohol Dehydrogenase in Saccharomyces cerevisiae. II. Two Loci Controlling Synthesis of the Glucoserepressible ADHII. Mol. Gen. Genet. 138, 157–164.
Ellis, R.W., Kinskern, P.J., Hagopian, A., Schultz, L.D., Montgomery, D.L., Maigetter, R.Z., Wampler, D.E., Emini, E.A., Wolanski, B., McAleer, W.J., Hurni, W.M., Miller, W.J. (1988), Preparation and Testing of a Recombinant-derived Hepatitis B Vaccine Consisting of PreS2+S Polypepties, “Viral Hepatitis and Liver Disease”, A.J. Zuckerman (ed.). Alan R. Liss, New York, pp. 1079–1086.
Ellis, R.W. (1989),Recombinant Yeast-derived Hepatitis B Vaccine: The Prototype for Biotechnologically-derived Old Vaccines. For submission to: “Biotechnology Handbook”, Chiu and Gueriguian, Editors, New York, Marcel Dekker.
Emini, E.A., Ellis, R.W., Miller, W.J., McAleer, W.J., Scolnick, E.M. and Gerety, R.J. (1986), Production and Immunological Analysis of Recombinant Hepatitis B Vaccine. J. Inf. 13(A), 3–9.
Emini, E.A., Larson, V., Eichberg, J., Conard, P., Garsky, V.M., Lee, D.R., Ellis, R.W., Miller, W.J., Anderson, C.A. and Gerety, R.J. (1989), A Synthetic Peptide Comprising the Complete PreS2 Region of the Hepatitis B Virus (HBV) Surface Protein Confers Protection in Chimpanzees Against HBV Challenge. Submitted to J. Med. Virology.
Francis, D.P., Hadler, S.C., Thompson, S.E, Maynard, J.E., Ostrow, D.G., Altman, N., Braff, E.H., O’Malley, P., Hawkins, D., Judson, F.N., Penley, K., Nylund, T., Christie, G., Mayers, F., Moore, J.N., Gardner, A., Doto, I.L., Miller, J.H., Reynolds, G.H., Murphy, B.L., Schable, C.A., Clark, B.T., Curran, J.W. and Redeker, A.G. (1982), The Prevention of Hepatitis B with Vaccine. Ann. Int. Med. 97, 362–366.
Francis, D.P., Feorino, P.M., McDougal, S., Warfield, D., Getchell, J., Cabradilla, C., Tong, M., Miller, W.J., Schultz, L.D., Bailey, F.J., McAleer, W.J., Scolnick, E.M. and Ellis, R.W. (1986), The Safety of the Hepatitis B Vaccine. J. Am. Med. Assn. 256, 869–872.
Galibert, F., E. Mandart, F. Fitoussi, P. Tiollais and P. Charnay (1979), Nucleotide Sequence of the Hepatitis B Genome (subtype ayw) Cloned in E, coli. Nature (London) 281, 646–650.
Hashimoto, H., Kikuchi, Y., Nogi, Y. and Fukasawa, T. (1983), Regulation of Expression of the Galactose Gene Cluster in Saccharomyces cerevisiae — Isolation and Characterization of. the Regulatory Gene GAL4. Mol. Gen. Genet. 191, 31–38.
Heermann, K.H., Goldmann, U., Schwartz, W., Seyffarth, T., Baumgarten, H., Gerlich, W.H. (1984), Large Surface Proteins of Hepatitis B Virus Containing the Pre-S Sequence. Journal of Virology 52, 396–402.
Hilleman, M.R., Bertland, A.V., Buynak, E.B., Lampson, G.P., McAleer, W.J., Roehm, R.R. and Tytell, A.A. (1978), Clinical Laboratory Studies of HBsAg Vaccine, Viral Hepatitis (G.N. Vyas, S.N. Cohen and R. Schmid, eds.). Franklin Institute Press, Philadelphia, pp. 525–537.
Hilleman, M.R., McAleer, W.J., Buynak, E.B. and McLean, A.A. (1983), The Preparation and Safety of Hepatitis B Vaccine. J. Infect. 7, 3–8.
Hilleman, M.R. and Ellis, R.W. (1986), Vaccines Made from Recombinant Yeast Cells. Vaccine 4, 75–76.
Hruska, J.F., Clayton, D.A., Rubenstein, J.L.R. and Robinson, W.S. (1977), Structure of Hepatitis B Dane Particle DNA Before and After the Dane Particle DNA Polymerase Reaction. J. Virology 21, 666–672.
Itoh, Y., Takai, E., Ohnuma, H., Kitajima, H., Tsuda, F., Machida, A., Mishiro, S., Nakamura, T., Miyakaway, Y., Mayumi, M. (1986), A Synthetic Peptide Vaccine Involving the Product of the Pre-S(2) Region of Hepatitis B Virus DNA: Protective Efficacy in Chimpanzees. Proc. Natl. Acad. Sci. USA 83. 9174–9178.
Iwarson, S., Tabor, E., Thomas, H.C., Godall, A., Waters, J., Snoy, P., Shih, J.W.-K. and Gerety, R.J. (1985), Neutralization of Hepatitis B Virus Infectivity by a Murine Monoclonal Antibody: An Experimental Study in the Chimpanzee. J. Med. Virol. 16, 89–96.
Jilg, W., Schmidt, M., Weinel, B., Kuttler, Th., Brass, H., Bommer, J., Muller, R., Schulte, B., Schwarzbeck, A. and Deinhardt, F. (1986), Immunogenicity of Recombinant Hepatitis B Vaccine in Dialysis Patients. J. Hepatology 3, 190–195.
Johnston, S.A. and Hopper, J.E. (1982), Isolation of the Yeast Regulatory Gene GAL4 and Analysis of its Dosage Effects on the Galactose/ Melibiose Regulon. Proc. Natl. Acad. Sci. USA 79, 6971–6975.
Johnston, S.A., Zavortink, M.J., Debouck, C. and Hopper, J.E. (1986), Functional Domains of the Yeast Regulatory Protein, GAL4. Proc. Natl. Acad. Sci. USA 83, 6553–6557.
Kniskern, P.J., Hagopian A., Montgomery, D.L., Burke, P., Dunn, N.R., Hofmann, K.J., Miller, W.J., Ellis, R.W. (1986), Unusually High-Level Expression of a Foreign Gene (Hepatitis B Virus Core Antigen) in Saccharomyces cerevisiae. Gene 46, 135–141.
Kniskern, P.J., Hagopian, A., Burke, P., Dunn, N.R., Emini, E.A., Miller, W.J., Yamazaki, S. and Ellis, R.W. (1988), A Candidate Vaccine for Hepatitis B Containing the Complete Viral Surface Protein. Hepatology 8. 82–87
Kniskern, P.J., Montgomery, D.L., Carty, C.E., Burke, P., Schulman, C.A., Hofmann, K.J., Bailey, F.J., Hagopian, A., Dunn, N.R., Maigetter, R.Z., Schultz, L.D., and Ellis R.W. (1989), Constitutive and Regulated Expression of Hepatitis B Virus (HBV) PreS2+S Protein in Yeast. For publication in: The ACS Symposium on Microbiological and Biochemical Technology.
Laughon, A., Driscoll, R., Wills, N. and Gesteland, R.F. (1984), Identification of Two Proteins Encoded by the Saccharomyces cerevisiae GAL4 gene. Mol. Cell. Biol. 4. 268–275.
McAleer, W.J., Buynak, E.B., Maigetter, R.Z., Wampler, D.E., Miller, W.J., Hilleman, M.R. (1984), Human Hepatitis B Vaccine from Recombinant Yeast. Nature 307, 178–180.
Milich, D.R., McNamara, M.K., McLachlan, A., Thornton, G.B., Chisari, F.V. (1985), Distinct H-2-linked Regulation of T-cell Responses to the Pre-S and S Regions of the Same Hepatitis B Surface Antigen Polypeptide Allows Circumvention of Nonresponsiveness to the S Region. Proc. Natl. Acad. Sci. USA 82, 8168–172.
Milich, D.R., McLachlan, A., Chisari, F.V., Kent, S.B., Thorton, G.B. (1986), Immune Response to the Pre-S(1) Region of the Hepatitis B Surface Antigen (HBsAg): A Pre-S(1)-specific T Cell Response can Bypass Nonresponsiveness to the Pre-S(2) and S Regions of HBsAg. J. Immunol. 137, 315–322.
Nasmyth, K.A. and Reed, S.I. (1980), Isolation of Genes by Complementation in Yeast: Molecular Cloning of a Cell-Cycle Gene. Proc. Natl. Acad. Sci. USA 77, 2119–2123.
Neurath, A.R., Kent, S.B., Strick, N., Stark, D., Sproul, P. (1985), Genetic Restriction of Immune Responsiveness to Synthetic Peptides Corresponding to Sequences in the Pre-S Region of the Hepatitis B Virus (HBV) Envelope Gene. J. Med. Virol. 17, 119–25.
Neurath, A.R., Kent, S.B., Parker, K., Prince, A.M., Strick, N., Brotman, B., Sproul, P. (1986), Antibodies to a Synthetic Peptide from the Pre-S 120–145 Region of the Hepatitis B Virus Envelope are Virus-Neutralizing. Vaccine 4, 35–37.
Neurath, A.R., Kent, S.B.H., Strick, N., Parker, K., Courouce, A.-M., Riottot, M.M., Petit, M.A., Budkowska, A., Girard, M., Pillot, J. (1987), Antibodies to Synthetic Peptides from the Pre-S1 and Pre-S2 Regions of One Subtype of the Hepatitis B Virus (HBV) Envelope Protein Recognize all HBV Subtypes. Molecular Immunology 24, 975–980.
Perlman, D. and Hopper, J.E. (1979), Constitutive Synthesis of the GAL4 Protein, a Galactose Pathway Regulator in Saccharomyces cerevisiae. Cell 16. 89–95.
Peterson, D.L., Roberts, I.M. and Vyas, G.N. (1977), Partial Amino Acid Sequence of Two Major Component Polypeptides of Hepatitis B Surface Antigen. Proc. Natl. Acad. Sci. U.S.A. 74, 1530–1534.
Prince, A.M., Ikram, H. and Hopp, T.P. (1982), Hepatitis B Virus Vaccine: Identification of HBsAg/a. and HBsAg/d but not HBsAg/y Subtype Antigenic Determinants on A Synthetic Immunogenic Peptide. Proc. Natl. Acad. Sci. (U.S.A.) 79, 579–582.
Robinson, W.S. and Marion, P.L. (1988), Biological Features of Hepadna Viruses, Viral Hepatitis and Liver Disease (A.J. Zuckerman, ed.), Alan R. Liss, Inc., N.Y., pp 449–458.
Schultz, L.D., Tanner, J., Hofmann, K.J., Emini, E.A., Condra, J.H., Jones, R.E., Kieff, E., Ellis, R.W. (1987a), Expression in Yeast of the Gene Encoding the Major Envelope Glycoproteins (gp350/gp220) of EpsteinBarr Virus. Gene 54, 113–123.
Schultz, L.D., Hofmann, K.J., Mylin, L.M., Montgomery, D.L., Ellis, R.W. and Hopper, J.E. (1987b), Regulated Overproduction of the GAL4 Gene Product Greatly Increases Expression from Galactose-Inducible Promoters on Multi-Copy Expression Vectors in Yeast. Gene 61, 121–133.
Stevens, C.E., Alter, H.J., Taylor, P.E., Zaug, E.A., Harley, E.J. and Szmuness, W. (1984), Hepatitis B Vaccine in Patients Receiving Hemodialysis: immunogenicity and efficacy. N. Engl. J. Med. 311, 496–501.
Stevens, C.E., Taylor, P.E., Tong, M.J., Toy, P.T., Vyas, G.N. and Krugman, S. (1987), Yeast-Recombinant Hepatitis B Vaccine: Efficacy with Hepatitis B Immune Globulin in Prevention of Perinatal Hepatitis B Virus Transmission. J. Am. Med. Assoc. 257, 2612–2616.
Szmuness, W. (1978), Hepatocellular Carcinoma and the Hepatitis B Virus: Evidence for a Causal Association. Prog. Med. Vir. 24, 40–69.
Szmuness, W., Harley, E.J., Ikram, H. and Stevens, C.E. (1978), Sociodemographic Aspects of the Epidemiology of HBV, Viral Hepatitis (G.N. Vyas, S.N. Cohen and R. Schmid, eds.), Franklin Institute Press, Philadelphia, pp. 297–320.
Szmuness, W., Stevens, C.E., Zang, E.A., Harley, E.J., Kellner (1981), A Controlled Clinical Trial of the Efficacy of the Hepatitis B Vaccine (Heptavax-B®): A Final Report. Hepatology 1, 377–385.
Tabor, E., Buynak, E.B., Smallwood, L.A., Snoy, P., Hilleman, M.R. and Gerety, R.J. (1983), Inactivation of Hepatitis B Virus by Three Methods: treatment with pepsin, urea, or formalin. J. Med. Virol 11, 1–10.
Tiollais, P., Pourcel, C., Dejean, A. (1985), The Hepatitis B Virus. Nature (London) 317, 489–495.
Valenzuela, P., Gray, P., Quiroga, M., Zaldivar, J., Goodman, H.M., Rutter, W.J. (1979), Nucleotide Sequence of the Gene Coding for the Major Protein of Hepatitis B Virus Surface Antigen. Nature 280, 815–819.
Valenzuela, P., M. Quiroga, J. Zaldivar, P. Gray and W.J. Rutter (1981), The Nucleotide Sequence of the Hepatitis B Viral Genome and the Identification of the Major Viral Genes, In B. Fields, R. Jaenisch and C.F. Fox (ed.), Animal virus genetics. Academic Press, Inc., New York, pp.57–70.
Valenzuela, P., Medina, A., Rutter, W.J., Ammerer, G., Hall, B.D. (1982), Synthesis and Assembly of Hepatitis B Virus Surface Antigen Particles in Yeast. Nature 298, 347–352.
Valenzuela, P., Coit, D., Kuo, C.H. (1985), Synthesis and Assembly in Yeast of Hepatitis B Virus Surface Antigen Particles Containing the Polyalbumin Receptor. Biotechnology 3, 317–320.
Wampler, D.E., Lehman, E.D., Boger, J., McAleer, W.J. and Scolnick, E.M. (1985), Multiple Chemical Forms of Hepatitis B Surface Antigen Produced in Yeast. Proc. Natl. Acad. Sci. U.S.A. 82, 6830–6834.
West, D.J., Zajac, B.A., Ellis, R.W. and Gerety, R.J. (1988), Improved Immunogenicity of a Yeast-Derived Hepatitis B Vaccine. Infektionsklinik 1, 1–7.
Zajac, B.A., West, D.J., McAleer, W.J. and Scolnick, E.M. (1986), Overview of Clinical Studies with Hepatitis B Vaccine Made by Recombinant DNA. J. Infect. 13(A), 39–45.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kniskern, P.J. et al. (1989). The Application of Molecular Biology to the Development of Novel Vaccines. In: Atassi, M.Z. (eds) Immunobiology of Proteins and Peptides V. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2046-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2046-4_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-2048-8
Online ISBN: 978-1-4757-2046-4
eBook Packages: Springer Book Archive